Clinical Trials Directory

Trials / Completed

CompletedNCT01689090

Diameter Changes of Retinal Vessels During Hypoxia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.

Conditions

Interventions

TypeNameDescription
OTHERCOX inhibitorAdministration of 1 drop voltaren 45 minutes before recordings of diameter changes of retinal vessels are initiated
OTHERL-NG-monomethyl arginine citrateIntravenous administration of L-NMMA during recordings of diameter changes of retinal vessels
OTHERCOX inhibitor + L-NG-monomethyl arginine citrateCombination of interventions. Administration of an eye drop voltaren and 45 minutes later infusion with L-NMMA is started and recording of diameter changes of retinal vessels is performed

Timeline

Start date
2012-11-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2012-09-20
Last updated
2018-10-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01689090. Inclusion in this directory is not an endorsement.